Oxandrolone (Anavar)

08/01/2004 - "LBM was significantly greater with oxandrolone at 6, 9, and 12 months after the burn (P < .001) and BMC at 12 months (P < .016). "
08/01/2007 - "Oxandrolone is safe and effective in promoting anabolism in large burns. "
09/01/2005 - "To study the efficacy of oxandrolone in severely burned children for 12 months after burn and 12 months after the drug was discontinued. "
03/31/2022 - "These findings suggest the efficacy of oxandrolone in preventing muscle catabolism as a part of hypermetabolism in burn patients. "
05/01/2007 - "Oxandrolone has been shown to improve lean muscle mass in patients with burns. "

07/02/1982 - "[Improvement in the longitudinal growth in Ullrich-Turner syndrome with oxandrolone. "
01/01/2021 - "Effect of oxandrolone and timing of pubertal induction on final height in Turner syndrome: final analysis of the UK randomised placebo-controlled trial."
01/01/2015 - "Eligible trials were identified by a literature search using the terms: Turner syndrome, oxandrolone. "
04/14/2011 - "Effect of oxandrolone and timing of pubertal induction on final height in Turner's syndrome: randomised, double blind, placebo controlled trial."
03/01/2015 - "Long-term effects of oxandrolone treatment in childhood on neurocognition, quality of life and social-emotional functioning in young adults with Turner syndrome."

11/01/1993 - "A cohort of 273 male patients enrolled in a Department of Veterans Affairs Cooperative Study performed to evaluate the efficacy of oxandrolone in combination with nutritional supplementation in moderate or severe alcoholic hepatitis. "
04/01/1993 - "A Veterans Affairs cooperative study involving 273 male patients was performed to evaluate efficacy of oxandrolone in combination with an enteral food supplement in severe alcoholic hepatitis. "
09/01/1991 - "We conclude that the addition of nutritional supplementation and oxandrolone to standard therapy of moderately severe or severe alcoholic hepatitis is well tolerated, and leads to more rapid improvement in the laboratory parameters measured."
04/01/1993 - "A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study."
09/01/1991 - "A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. "

02/01/2009 - "In clinical studies, oxandrolone 10 mg orally twice/day improved wound healing, restored lean body mass, and accelerated body weight gain. "
03/01/2006 - "Body weight increased in all groups, including the group receiving placebo, during the double-blind phase (1.1 +/- 2.7, 1.8 +/- 3.9, 2.8 +/- 3.3, and 2.3 +/- 2.9 kg in placebo and 20-, 40-, and 80-mg oxandrolone groups, respectively; all P < 0.014 vs. baseline). "
12/01/2003 - "We found that the body weight and lean mass which was restored during RH, was maintained 6 months after discontinuation of oxandrolone. "
06/01/2003 - "Body weights and fat free mass significantly decreased in the placebo group, while no changes were found in the oxandrolone-treated subjects. "
12/01/1996 - "In a multicenter, double-blind study, 63 HIV-seropositive men with > 10% loss of body weight were randomized to receive either placebo, 5 mg/day oxandrolone, or 15 mg/day oxandrolone for 16 weeks. "

01/01/2009 - "Larger studies are needed to determine if oxandrolone is an effective, safe, and affordable option to stimulate appetite, improve weight gain, and promote linear growth in patients with CF."
11/01/1997 - "Oxandrolone for weight gain."
12/01/1996 - "Patients who received 15 mg/day oxandrolone showed weight gain throughout the 16-week treatment period. "
05/01/1999 - "The effect of one-month treatment with oxandrolone on weight gain and pulmonary function was studied in ten subjects with complete motor tetraplegia. "
11/01/1997 - "Oxandrolone, an oral drug that promotes weight gain in people experiencing weight loss, has been approved by the Food and Drug Administration (FDA) for patients with HIV. "